González-Ferrero Teba, Bergonti Marco, Marcon Lorenzo, Minguito-Carazo Carlos, Tilves Bellas Carlos, Pesquera Lorenzo Juan Carlos, Martínez-Sande José Luis, González-Melchor Laila, García-Seara Francisco Javier, Fernández-López Jesús Alberto, González-Juanatey José Ramón, Heidbuchel Hein, Sarkozy Andrea, Rodríguez-Mañero Moisés
Division of Cardiac Electrophysiology, Department of Cardiology, University Hospital Lucus Augusti, Lugo, Spain.
Translational Cardiology Group, Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, A Coruña, Spain.
Clin Res Cardiol. 2025 Jan;114(1):126-137. doi: 10.1007/s00392-024-02467-6. Epub 2024 Jun 26.
Although atrial fibrosis has a relevant impact on ablation success rate, experimental studies have reported that extensive fibrosis may be accompanied by a reduced burden secondary to a prominent depression of atrial excitability.
We aimed to identify clinical and echocardiographic factors associated with extensive left atrial myopathy (ELAM), to analyze the predictive ability of established scores (AF score, APPLE, and DR-FLASH) and assess outcomes in terms of AF recurrence, left atrial flutter, and post-procedural heart failure admissions.
A total of 950 consecutive patients undergoing the first AF ablation were included. A 3D electroanatomical mapping system (CARTO3, Biosense Webster) was created using a multipolar mapping catheter (PentaRay, Biosense Webster). ELAM was defined as ≥ 50% low voltage area. A subanalysis with four groups was also created (< 10%; 10-20%; 10-20%; and > 30%). Logistic regressions, Cox proportional hazards models, and log-rank test were used to test the predictors independently associated with the presence of ELAM and AF recurrence. The model was prospectively validated in a cohort of 150 patients obtaining an excellent ability for prediction AUC 0.90 (CI 95% 0.84-0.96).
Overall, 78 (8.42%) presented ELAM. Age, female sex, persistent AF, first-degree AV block, and E/e' were significant predictors. The model incorporating these factors outperformed the existing scores (AUC = 0.87). During a mean follow-up of 20 months (IQR 9 to 36), patients with ELAM presented a higher rate of AF recurrence (42.02% vs 26.01%, p = 0.030), left atrial flutter (26.03% vs 8.02%, p < 0.001), and post-procedural heart failure admissions (12.01% vs 0.61%, p < 0.001) than non-ELAM patients.
This study reveals the incidence and clinical factors associated with ELAM in AF, highlighting age, female, persistent AF, first-degree AV block, and E/e'. Importantly, the presence of ELAM is associated with poorer outcomes in terms of recurrence and HF admission.
尽管心房纤维化对消融成功率有显著影响,但实验研究报告称,广泛的纤维化可能伴随着心房兴奋性显著降低导致的负担减轻。
我们旨在确定与广泛左心房肌病(ELAM)相关的临床和超声心动图因素,分析既定评分(AF评分、APPLE和DR-FLASH)的预测能力,并评估房颤复发、左心房扑动和术后心力衰竭入院方面的结果。
共纳入950例连续接受首次房颤消融的患者。使用多极标测导管(PentaRay,Biosense Webster)创建三维电解剖标测系统(CARTO3,Biosense Webster)。ELAM定义为低电压区域≥50%。还创建了一个包含四组的亚分析(<10%;10%-20%;20%-30%;>30%)。使用逻辑回归、Cox比例风险模型和对数秩检验来测试与ELAM存在和房颤复发独立相关的预测因素。该模型在150例患者的队列中进行了前瞻性验证,预测AUC为0.90(95%CI 0.84-0.96),具有出色的预测能力。
总体而言,78例(8.42%)出现ELAM。年龄、女性、持续性房颤、一度房室传导阻滞和E/e'是显著的预测因素。纳入这些因素的模型优于现有评分(AUC = 0.87)。在平均20个月(IQR 9至36)的随访期间,ELAM患者的房颤复发率(42.02%对26.01%,p = 0.030)、左心房扑动率(26.03%对8.02%,p < 0.001)和术后心力衰竭入院率(12.01%对0.61%,p < 0.001)均高于非ELAM患者。
本研究揭示了房颤中与ELAM相关的发病率和临床因素,突出了年龄、女性、持续性房颤、一度房室传导阻滞和E/e'。重要的是,ELAM的存在与复发和心力衰竭入院方面的较差结果相关。